加速康复外科方案对头颈大手术术后并发症及辅助治疗实施的影响
本研究比较39例加速康复外科(ERAS)患者与39例历史对照的喉或口腔切除游离皮瓣重建患者,发现ERAS改善住院时间(p=0.005)并更早恢复日常生活活动(ADL)(p=0.004、0.001),ADL恢复与按时辅助治疗(≤42天)相关(OR 1.36),但ERAS组辅助治疗延迟虽较少(51.3% vs 69.2%),多因素回归后未达显著(p=0.11)。
要点
- ERAS改善住院时间并更早恢复日常生活活动。
- ADL恢复独立预测按时辅助治疗(≤42天)。
- ERAS组TAT延迟较少但多因素分析未显著。
核心结论
- ERAS缩短住院时间并使晚期头颈癌患者更早恢复日常生活活动。
- 术后ADL恢复独立预测按时辅助治疗。
- TAT≤6周的CoC质量指标依从性仍超过50%未达标,是主要治疗障碍。
研究设计与样本
- 单机构三级转诊中心研究,比较2018年后接受喉或口腔切除游离皮瓣重建、ERAS及辅助治疗的患者与历史前ERAS队列。
- 前ERAS组39例,ERAS组39例。
主要发现
- ERAS组住院时间改善(p=0.005)。
- ERAS组出院回家和恢复ADL更早(p=0.004、0.001)。
- 单因素分析中ADL恢复与按时TAT≤42天相关(OR 1.36,95% CI 1.13-1.63,p=0.001)。
- TAT延迟ERAS组51.3% vs 前ERAS组69.2%,多因素逻辑回归后不显著(p=0.11)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Commission on Cancer (CoC) recently introduced a quality metric to optimize time between major head and neck surgery and adjuvant treatment (TAT) ≤6 weeks, as TAT delay adversely impacts patient survival. This study evaluates whether enhanced recovery after surgery (ERAS) for this population reduces the rate of postoperative complications, length of stay (LOS), and TAT. METHODS: Patients undergoing larynx or oral cavity resection with free flap reconstruction, ERAS, and adjuvant treatment after 2018 were compared to a historical pre-ERAS cohort. Patients underwent surgery at a single-institution tertiary referral center for complex head and neck oncology. Differences between groups were compared by chi-square, Fisher's exact, or Wilcoxon rank-sum test. TAT >6 weeks was evaluated with univariate and multivariable logistic regression. RESULTS: Thirty-nine pre-ERAS patients were compared to 39 ERAS patients. No demographic differences existed between groups. LOS was improved with ERAS (p = 0.005). ERAS patients were discharged to home and returned to their activities of daily living (ADL) earlier (p = 0.004, 0.001). ADL recovery was associated with on-time TAT ≤42 days on univariate analysis (OR 1.36, 95% CI 1.13-1.63, p = 0.001). TAT delay was less frequent with ERAS (51.3% vs. 69.2%), but this was not significant after multivariable logistic regression (p = 0.11). CONCLUSION: ERAS decreases LOS and returns advanced head and neck cancer patients to their ADL sooner. Postoperative ADL recovery independently predicts on-time adjuvant treatment. Still, compliance beyond 50% with the TAT ≤6 weeks CoC quality metric remains a major treatment barrier.
引用
- Frenkel CH, Donahue EE, Cochran A, et al. The impact of an enhanced recovery after surgery protocol for major head and neck oncologic surgery on postoperative complications and adjuvant treatment delivery. Head Neck. 2024. PMID: 39072915. doi:10.1002/hed.27890
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。